Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update

With the aging of the population, malignancies are becoming common complications in patients with rheumatoid arthritis (RA), particularly in elderly patients. Such malignancies often interfere with RA treatment. Among several therapeutic agents, immune checkpoint inhibitors (ICIs) which antagonize i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Quang Minh, Watanabe, Ryu, Shiomi, Mayu, Fukumoto, Kazuo, Nobashi, Tomomi W., Okano, Tadashi, Yamada, Shinsuke, Hashimoto, Motomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051463/
https://www.ncbi.nlm.nih.gov/pubmed/36982715
http://dx.doi.org/10.3390/ijms24065643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051463/
https://www.ncbi.nlm.nih.gov/pubmed/36982715
http://dx.doi.org/10.3390/ijms24065643

Ejemplares similares